Can Handwriting Speed Predict Cognitive Decline?

Summary: The timing and structural organization of handwriting can serve as an objective, non-invasive biomarker for cognitive decline. Researchers in Portugal used a digital inking pen and tablet to detect subtle motor fluctuations that standard pen-and-paper tests miss, showing that complex dictation tasks strain working memory and executive functions and reveal fragmentation and uncoordinated handwriting movements in older adults with cognitive impairment.

By recording pen kinematics on a digitizing tablet, the team demonstrated that demanding dictation exercises reveal cognitive deficits through measurable changes in stroke timing, number of strokes, letter size, and total writing duration—features that simple motor tasks do not expose.

Key Facts

  • A window into the brain: Handwriting combines fine motor control with sensory processing, organization, working memory, and executive control, making it a cognitively demanding task sensitive to decline.
  • Digital tablet setup: The study evaluated 58 older adults (ages 62–92) living in care homes; 38 of them had a prior diagnosis of cognitive impairment. Participants completed writing tasks using an active inking pen on a digitizing tablet.
  • Simple tasks are not enough: Basic pen-control activities (drawing horizontal lines or tapping dots) did not distinguish between groups, as they mostly rely on automated motor skills preserved in early decline.
  • Dictation functions as a cognitive stress test: Sentence dictation produced clear, statistically significant differences. Dictation forces listening, language processing, phoneme-to-grapheme conversion, working memory, and motor execution to operate together.
  • Predictors of impairment: For short dictated sentences, start time and number of strokes predicted cognitive status. For longer, more complex sentences, vertical letter size, start time, and total duration became dominant indicators.
  • Clinical scalability: Because the method uses inexpensive digital tools and brief writing tasks, it could be integrated into routine clinical settings as a low-cost, non-invasive screening and monitoring tool for cognitive decline.

Source: Frontiers

Handwriting demands precise motor control and a complex set of mental processes—selecting, organizing, interpreting sensory input, and coordinating movement—so changes in how someone writes can signal cognitive decline. As people age, handwriting often becomes slower, more fragmented, or less coordinated, and these changes may reflect underlying deficits in executive function and working memory.

In a Frontiers in Human Neuroscience study, researchers from Portugal tested whether kinematic handwriting features—such as speed, stroke organization, and timing—differ between older adults with cognitive impairment and those without, and whether these features can act as diagnostic indicators.

This shows an older person writing.
Digitized handwriting data published in Frontiers in Human Neuroscience reveals that complex dictation tasks function as an executive stress test, exposing early cognitive decline through measurable changes in stroke timing and fragment patterns. Credit: Neuroscience News

“Writing is not just a motor activity; it’s a window into the brain,” said senior author Dr. Ana Rita Matias, assistant professor at the Department of Sport and Health at the University of Évora. The researchers found distinct timing and organizational patterns in the handwriting of older adults with cognitive impairment, especially during tasks with higher cognitive demand.

Ready, set, write

The team investigated whether real-time measures of the writing process could provide earlier or more sensitive signs of cognitive decline than final test scores or visual inspection alone. Fifty-eight institutionalized older adults (20 cognitively healthy and 38 cognitively impaired, classified using education-adjusted MMSE cutoffs) completed pen-control tasks and handwriting-speed tasks on a digitizing tablet.

Pen-control tasks included drawing 10 horizontal lines in 20 seconds and tapping at least 10 dots in 20 seconds. Handwriting-speed tasks involved copying two sentences and writing two dictated sentences that varied in complexity. Nine standardized kinematic variables were extracted and analyzed using logistic and multiple linear regression, corrected for multiple comparisons.

Pen-control tasks did not reliably differentiate cognitive status, confirming that simple, automated motor tasks are often insufficient to reveal early cognitive differences. Copying tasks showed a trend toward group differences but were still less sensitive than dictation.

Dictation tasks produced clear group differences, likely because they impose a high cognitive load on working memory and executive function. “Dictation requires the brain to listen, process language, hold words in working memory, convert sounds into written symbols, and coordinate fine motor actions simultaneously,” Matias explained. Longer or linguistically demanding sentences increase that strain and reveal impairments more clearly.

Among participants with cognitive impairment, start time and number of strokes were significant predictors for the shorter dictation sentence. For the longer, more complex dictated sentence, vertical letter size, start time, and total duration were significant predictors. These results suggest different handwriting features vary in sensitivity depending on cognitive load.

“Timing and stroke organization closely reflect how the brain plans and executes actions,” Matias noted. “When working memory and executive control weaken, handwriting becomes slower, more fragmented, and less coordinated. Other features may remain relatively intact in early stages and therefore are less sensitive.”

Routine writing for routine care

The researchers emphasize that this digitally mediated handwriting approach is low-cost, non-invasive, and easily deployable with common digital tablets and simple software. It could be used as a quick screening or monitoring tool in doctors’ offices, care homes, and other clinical settings to track cognitive trajectories over time.

However, the method is still emerging. Larger, longer-term studies across diverse populations are needed to validate and refine predictive models and to assess factors such as medication effects, comorbidities, and cultural or educational differences in writing behavior.

“The long-term goal is a quick, affordable assessment that integrates into routine healthcare without specialized equipment,” Matias said. If validated, digitized dictation tasks could complement traditional cognitive assessments and provide an objective, continuous measure of motor–cognitive interaction through handwriting kinematics.

Frequently asked questions

Q: If my handwriting has always been messy or slow, does that mean I am at risk for cognitive decline?

A: No. The technique does not judge handwriting aesthetics. It evaluates efficiency and coherence relative to an individual baseline. The system detects when writing becomes slower, choppier, or more fragmented compared with that person’s typical pattern, indicating changes in how the brain organizes motor strokes.

Q: Why does a dictation test reveal problems when a basic drawing test does not?

A: Drawing simple lines or dots is mostly an automated motor activity. Dictation requires simultaneous language decoding, working memory, and motor planning, acting like a mental multitasking stress test. When executive systems falter, hesitation and fragmentation appear in the handwriting.

Q: How soon might digital pen tracking be used in routine clinical practice?

A: The field requires further validation in larger and more diverse samples before becoming a clinical standard. Because the tools are inexpensive and non-invasive, the goal is to integrate a quick handwriting scan into everyday healthcare once predictive models are robustly validated.

Editorial notes

  • This article was edited by a Neuroscience News editor.
  • Journal paper reviewed in full.
  • Additional context added by staff.

About this research

Author: Deborah Pirchner
Source: Frontiers
Contact: Deborah Pirchner – Frontiers
Image credit: Neuroscience News

Original research: Open access. “Handwriting Speed and Pen Motor Control in Older Adults With and Without Cognitive Impairment” by João Galrinho, Orlando Fernandes, Ana Rita Silva, Marta A. Gonçalves-Montera, and Ana Rita Matias. Frontiers in Human Neuroscience. DOI: 10.3389/fnhum.2026.1820193


Abstract

Handwriting Speed and Pen Motor Control in Older Adults With and Without Cognitive Impairment

Background:

Handwriting is a hierarchical cognitive–motor activity that integrates motor execution, visuospatial processing, working memory, and executive control. Digital handwriting captures both process (kinematics) and product (written output), providing a theoretically grounded method for detecting cognitive vulnerability with aging.

Methods:

Fifty-eight institutionalized older adults (20 cognitively healthy, 38 cognitively impaired) completed pen-control tasks (DOTS, LINES) and four handwriting-speed tasks (two copy, two dictation) on a digitizing tablet. Nine standardized kinematic variables were analyzed using logistic and multiple linear regression models with corrections for multiple comparisons.

Results:

Pen-control tasks did not significantly discriminate between groups. Handwriting-speed tasks—especially dictation—revealed significant group differences. Temporal efficiency and stroke-organization variables (Duration, Number of Strokes, Start Time, Vertical Size) significantly contributed to classification under high cognitive load. Cognitively impaired participants showed stronger coupling between kinematic process measures and written-product performance than cognitively healthy participants.

Conclusion:

Handwriting kinematics—particularly temporal and stroke-related features measured during high cognitive–motor demand tasks—are sensitive indicators of cognitive impairment. Digitally mediated dictation paradigms show promise as ecologically valid, low-cost screening and monitoring tools for cognitive decline in older adults.

Clinical trial registration: ClinicalTrials.gov, NCT06483438.